6-methylene-4-pregnene-3,20-dione has been researched along with raloxifene hydrochloride in 1 studies
| Studies (6-methylene-4-pregnene-3,20-dione) | Trials (6-methylene-4-pregnene-3,20-dione) | Recent Studies (post-2010) (6-methylene-4-pregnene-3,20-dione) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 2,818 | 481 | 810 |
| Protein | Taxonomy | 6-methylene-4-pregnene-3,20-dione (IC50) | raloxifene hydrochloride (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0053 | |
| Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, LW; Neubauer, BL; Petrow, V; Sikes, RA; Thomsen, S | 1 |
1 other study(ies) available for 6-methylene-4-pregnene-3,20-dione and raloxifene hydrochloride
| Article | Year |
|---|---|
Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Azasteroids; Dihydrotestosterone; DNA; Drug Therapy, Combination; Estrogen Antagonists; Female; Male; Mice; Mice, Inbred BALB C; Orchiectomy; Piperidines; Progesterone; Prostatic Hyperplasia; Raloxifene Hydrochloride; Urogenital System | 1990 |